Literature DB >> 27754827

High mobility group box 1 induces the activation of the Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway in pancreatic acinar cells in rats, while AG490 and rapamycin inhibit their activation.

Guoliang Wang1, Jingchao Zhang, Danhua Dui, Haoyuan Ren, Jin Liu.   

Abstract

The pathogenesis of severe acute pancreatitis (SAP) remains unclear. The Janus kinase and signal transducer and activator of transcription (JAK/STAT) pathway is important for various cytokines and growth factors. This study investigated the effect of the late inflammatory factor high mobility group box 1 (HMGB1) on the activation of JAK2/STAT3 in pancreatic acinar cells and the inhibitory effects of AG490 (a JAK2 inhibitor) and rapamycin (a STAT3 inhibitor) on this pathway. Rat pancreatic acinar cells were randomly divided into the control, HMGB1, AG490, and rapamycin groups. The mRNA levels of JAK2 and STAT3 at 10, 30, 60, and 120 minutes were detected using reverse transcription polymerase chain reaction (RT-PCR). The protein levels of JAK2 and STAT3 at 60 and 120 minutes were observed using Western blotting. Compared with the control group, the HMGB1 group exhibited significantly increased levels of JAK2 mRNA at each time point; STAT3 mRNA at 30, 60, and 120 minutes; and JAK2 and STAT3 proteins at 60 and 120 minutes (p < 0.01). Compared with the HMGB1 group, the AG490 and rapamycin groups both exhibited significantly decreased levels of JAK2 mRNA at each time point (p < 0.05); STAT3 mRNA at 30, 60, and 120 minutes (p < 0.01); and JAK2 and STAT3 proteins at 60 and 120 minutes (p < 0.01). HMGB1 induces the activation of the JAK2/STAT3 signaling pathway in rat pancreatic acinar cells, and this activation can be inhibited by AG490 and rapamycin. The results of this study may provide new insights for the treatment of SAP.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27754827      PMCID: PMC5136768          DOI: 10.17305/bjbms.2016.1442

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  17 in total

1.  Immunology. Dangers in and out.

Authors:  Marco E Bianchi; Angelo A Manfredi
Journal:  Science       Date:  2009-03-27       Impact factor: 47.728

Review 2.  Severe acute pancreatitis: advances and insights in assessment of severity and management.

Authors:  Giuseppe Brisinda; Serafino Vanella; Anna Crocco; Andrea Mazzari; Pasquina Tomaiuolo; Francesco Santullo; Ugo Grossi; Antonio Crucitti
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-07       Impact factor: 2.566

3.  The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.

Authors:  Ping Chen; Liya Huang; Yongping Zhang; Minmin Qiao; Weiyan Yao; Yaozong Yuan
Journal:  Int J Mol Med       Date:  2011-03-01       Impact factor: 4.101

4.  Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

Authors:  Carmen Fiuza; Michael Bustin; Shefali Talwar; Margaret Tropea; Eric Gerstenberger; James H Shelhamer; Anthony F Suffredini
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

Review 5.  The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.

Authors:  Bin Cai; Jian-ping Cai; Yu-long Luo; Cheng Chen; Sen Zhang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

6.  IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism.

Authors:  Beatriz Rendon-Mitchell; Mahendar Ochani; Jianhua Li; Jialian Han; Hong Wang; Huan Yang; Seenu Susarla; Christopher Czura; Robert A Mitchell; Guoqian Chen; Andrew E Sama; Kevin J Tracey; Haichao Wang
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.

Authors:  Takeo Yasuda; Takashi Ueda; Yoshifumi Takeyama; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  Pancreas       Date:  2006-11       Impact factor: 3.327

8.  The role of organ failure and infection in necrotizing pancreatitis: a prospective study.

Authors:  Qiang Guo; Ang Li; Qing Xia; Xubao Liu; Bole Tian; Gang Mai; Zongwen Huang; Guangyuan Chen; Wenfu Tang; Xiaodong Jin; Weixia Chen; Huimin Lu; Nengwen Ke; Zhaoda Zhang; Weiming Hu
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

9.  High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes.

Authors:  U Andersson; H Wang; K Palmblad; A C Aveberger; O Bloom; H Erlandsson-Harris; A Janson; R Kokkola; M Zhang; H Yang; K J Tracey
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

10.  Formal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsis.

Authors:  Rehan Zafar Paracha; Jamil Ahmad; Amjad Ali; Riaz Hussain; Umar Niazi; Samar Hayat Khan Tareen; Babar Aslam
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

View more
  4 in total

1.  Intestinal epithelial HMGB1 inhibits bacterial infection via STAT3 regulation of autophagy.

Authors:  Yong-Guo Zhang; Xiaorong Zhu; Rong Lu; Jeannette S Messer; Yinglin Xia; Eugene B Chang; Jun Sun
Journal:  Autophagy       Date:  2019-04-09       Impact factor: 16.016

2.  Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway.

Authors:  Chengyi Huang; Yufeng Yu
Journal:  Med Sci Monit       Date:  2017-03-29

Review 3.  The mechanism of HMGB1 secretion and release.

Authors:  Ruochan Chen; Rui Kang; Daolin Tang
Journal:  Exp Mol Med       Date:  2022-02-25       Impact factor: 12.153

4.  Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.

Authors:  Cong Han; Baocun Sun; Xiulan Zhao; Yanhui Zhang; Qiang Gu; Fang Liu; Nan Zhao; Lili Wu
Journal:  Technol Cancer Res Treat       Date:  2017-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.